US Stock MarketDetailed Quotes

ALLT Allot

Watchlist

2.110
-0.040-1.86%

Close Apr 29 16:00 ET

81.11MMarket Cap-1271P/E (TTM)

Allot Stock Forum

Moomoo AI

Dec 7, 2023 18:38

Shareholders of Allot may be disgruntled due to the firm's poor recent performance and excessive CEO compensation. A review of executive pay could be on cards considering the sharp drop in EPS and investor loss over the past three years.

Here's Why It's Unlikely That Allot Ltd.'s (NASDAQ:ALLT) CEO Will See A Pay Rise This Year

Moomoo AI

Nov 3, 2023 18:42

The stock's low P/S ratio, likely due to investors' doubt on robust revenue growth prospects and current conditions like declining revenues, could keep the share price low unless top-line growth substantially improves.

The Market Doesn't Like What It Sees From Allot Ltd.'s (NASDAQ:ALLT) Revenues Yet As Shares Tumble 27%

Mcsnacks H Tupack

Mar 16, 2022 15:24

Institutional buying

Top 4 why only 4? Because those are all that are buying
$Allot(ALLT.US)$ buy in 7.82 sell 12.25 after 8.23 the gaps are 9.76, 10.40, 11.34, 11.84 12.08.
$Synchronoss Technologies(SNCR.US)$ Buy in 1.59 sell 2.23.
$Puma Biotechnology(PBYI.US)$ buy in 2.72 sell 6.48.
$Avalo Therapeutics(AVTX.US)$ buy in .64. sell 1.76. Institutional investor has continued buying but the price may not have found bottom yet.

No comment yet

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall